Federal Funding Opens the Door to U.S. Ibogaine Trials

The federal government is moving to study ibogaine, a psychedelic with both anecdotal promise and documented cardiac risks, starting with safety-focused groundwork.

The federal government is moving to study ibogaine, a psychedelic with both anecdotal promise and documented cardiac risks, starting with safety-focused groundwork.